Clinical use of a combined-action antihypertensive medication urapidil

被引：0

作者：

Gaponova, N. I. ^{[1
]}

Abdrakhmanov, V. R. ^{[1
]}

Plavunov, N. F. ^{[2
]}

Filatov, A. V.

Orlov, V. S. ^{[2
]}

Filippo, D. V. ^{[2
]}

Tereshchenko, S. N. ^{[1
]}

机构：

[1] Moscow State Medicostomatol Univ, Moscow, Russia

[2] AS Puchkov Urgent Med Care Ctr, Moscow, Russia

来源：

CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 01期

关键词：

Arterial hypertension; antihypertensive therapy; hypertensive crise; urapidil; ARTERY BYPASS-SURGERY; HYPERTENSIVE URGENCIES; SODIUM-NITROPRUSSIDE; EMERGENCIES; INVITRO; NITROGLYCERIN; HYPOTENSION; PROFILE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Currently, combined antihypertensive therapy is considered as the leading strategy in the management of patients with arterial hypertension. One of the effective combined antihypertensive medications is a hybrid agent urapidil, which chemical structure provides a combination of central antihypertensive action and peripheral vasodilatation. This review discusses the results of the clinical and experimental studies on urapidil antihypertensive effectiveness. The clinical use of the medication, as well as its good tolerability and safety, is also discussed.

引用

页码：107 / 112

页数：6

共 37 条

[1] Effectiveness and safety of prehospital urapidil for hypertensive emergencies [J].